Literature DB >> 3977414

Prostaglandin E1 vasospastic disease and thermography.

V Kyle, G Parr, R Salisbury, P P Thomas, B Hazleman.   

Abstract

This is the first study to show a quantitative thermographic difference between patients with Raynaud's syndrome and normal controls after cold stress testing. An improved thermographic response to cold stress testing after treatment of Raynaud's syndrome with PGE1 has also been shown for the first time. Discriminant analysis of the change in temperature of a finger after cold stress, and the mean thermal gradient along the finger during rewarming, clearly separated patients from controls. After treatment with PGE1 the patients' discriminant values moved into the normal range. Symptomatic improvement after PGE1 correlated well with thermographic improvement, and both persisted for up to 12 weeks.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3977414      PMCID: PMC1001576          DOI: 10.1136/ard.44.2.73

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  7 in total

1.  Fate of prostaglandins E(1) and A(1) in the human pulmonary circulation.

Authors:  G L Hammond; L H Cronau; D Whittaker; C N Gillis
Journal:  Surgery       Date:  1977-06       Impact factor: 3.982

2.  Raynaud's phenomenon. Photoelectric plethysmography of the fingers of persons with and without Raynaud's phenomenon during cooling and warming up.

Authors:  A A Wouda
Journal:  Acta Med Scand       Date:  1977

3.  The effect of cold on blood flow in the hand of patients with Raynaud's phenomenon.

Authors:  J A Downey; D B Frewin
Journal:  Clin Sci       Date:  1973-03       Impact factor: 6.124

Review 4.  Raynaud syndrome.

Authors:  R J Blunt; J M Porter
Journal:  Semin Arthritis Rheum       Date:  1981-05       Impact factor: 5.532

5.  Prostaglandin E1 therapy for digital ulcers in scleroderma.

Authors:  M Baron; G Skrinskas; M B Urowitz; P N Madras
Journal:  Can Med Assoc J       Date:  1982-01-01       Impact factor: 8.262

6.  Assessment of cold sensitivity in Raynaud's phenomenon associated with scleroderma.

Authors:  K H Nilsen
Journal:  Microvasc Res       Date:  1978-03       Impact factor: 3.514

7.  Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis.

Authors:  M F Martin; P M Dowd; E F Ring; E D Cooke; P A Dieppe; J D Kirby
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

  7 in total
  7 in total

1.  A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases.

Authors:  H I Torley; R Madhok; H A Capell; R M Brouwer; P J Maddison; C M Black; H Englert; J A Dormandy; H R Watson
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 2.  Quantifying digital vascular disease in patients with primary Raynaud's phenomenon and systemic sclerosis.

Authors:  A L Herrick; S Clark
Journal:  Ann Rheum Dis       Date:  1998-02       Impact factor: 19.103

3.  Managing Raynaud's phenomenon.

Authors:  S Roath
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-12

4.  Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis.

Authors:  M Rademaker; R H Thomas; G Provost; J A Beacham; E D Cooke; J D Kirby
Journal:  Postgrad Med J       Date:  1987-08       Impact factor: 2.401

5.  Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis.

Authors:  N J McHugh; M Csuka; H Watson; G Belcher; A Amadi; E F Ring; C M Black; P J Maddison
Journal:  Ann Rheum Dis       Date:  1988-01       Impact factor: 19.103

6.  Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic Sclerosis.

Authors:  John D Pauling; Robyn T Domsic; Lesley A Saketkoo; Celia Almeida; Jane Withey; Hilary Jay; Tracy M Frech; Francesca Ingegnoli; Emma Dures; Joanna Robson; Neil J McHugh; Ariane L Herrick; Marco Matucci-Cerinic; Dinesh Khanna; Sarah Hewlett
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-08-16       Impact factor: 4.794

7.  Prolonged effect of CGRP in Raynaud's patients: a double-blind randomised comparison with prostacyclin.

Authors:  S Shawket; C Dickerson; B Hazleman; M J Brown
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.